ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2020

The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France.

Gérard de Pouvourville et al.PubMed ↗Publisher ↗

No numbers read from the abstract.